Exploring Building Better Treatments Panel Myasthenia Gravis
Exploring Building Better Treatments Panel Myasthenia Gravis reveals several interesting facts.
- James Howard Jr., MD, Distinguished Professor of Neuromuscular Disease and Professor of Neurology and
- At the 2024 MDA
- FcRn Modulation in
- Presented by: Gil I. Wolfe, MD, FAAN This information is not intended to replace discussions with your healthcare provider.
- Dr. Bonnie Gerecke from Mercy Medical Center explains how to
In-Depth Information on Building Better Treatments Panel Myasthenia Gravis
Join MDA Ambassadors, along with representatives from Vor Bio and Alexion Pharmaceuticals, for a discussion on the current ... Francesco Sacca, MD, PhD, University of Naples Federico II, Naples, Italy, discusses the Dr. Hans Katzberg, MD MSc FRCPC, presents the latest advancements in What is myasthenia gravis? Myasthenia gravis is an autoimmune disease that's categorized as a type II hypersensitivity that ...
What is
Stay tuned for more updates related to Building Better Treatments Panel Myasthenia Gravis.